Announcements Trials
Browse Landscape

Status

Terminated 2Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 54NETWORK 19NIH 5INDUSTRY 4

Study Type

Interventional 58Observational 4Expanded_access 3

Sponsor

Cancer Type

CNS 4

Conditions

Breast Neoplasms 467Neoplasms 315Carcinoma, Non-Small-Cell Lung 269Prostatic Neoplasms 215Colorectal Neoplasms 207Lung Neoplasms 176Multiple Myeloma 123Melanoma 110Carcinoma, Renal Cell 107Ovarian Neoplasms 94Carcinoma, Hepatocellular 78Pancreatic Neoplasms 69Urinary Bladder Neoplasms 65Stomach Neoplasms 64Neoplasm Metastasis 64Leukemia, Lymphocytic, Chronic, B-Cell 62Colonic Neoplasms 59Leukemia, Myeloid, Acute 53Uterine Cervical Neoplasms 50Recurrence 49Liver Neoplasms 46Lymphoma, Follicular 45Lymphoma 45Leukemia, Myelogenous, Chronic, BCR-ABL Positive 39Esophageal Neoplasms 37Precursor Cell Lymphoblastic Leukemia-Lymphoma 36Lymphoma, Large B-Cell, Diffuse 35Hematologic Neoplasms 35Head and Neck Neoplasms 35Lymphoma, Non-Hodgkin 34

Interventions

lorlatinib 1dinutuximab 1Data Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
INDUSTRY × Observational × Neuroblastoma × Clear all
NCT04753658 2024-09-23

Real World Data Collection Pediatric Neuroblastoma Treated With Lorlatinib

Pfizer

Terminated
15 enrolled 22 charts
CNS

Neuroblastoma

NCT04253015 2024-02-07

A Post-Authorisation Safety Study Patient Registry of Patients With Neuroblastoma Being Treated With Dinutuximab Beta

RECORDATI GROUP

Recruiting
125 enrolled
CNS

Brain Neoplasms, Neoplasms, Neuroblastoma

NCT05918432 2023-06-26

Determining Patterns In Study Experiences of Neuroblastoma Patients

Power Life Sciences Inc.

Not yet recruiting
500 enrolled
CNS

Neuroblastoma

NCT02693171 2019-08-05

Post-Marketing Assessment of Immunogenicity and Safety of Unituxin® in High-Risk Neuroblastoma Patients

United Therapeutics

Terminated
13 enrolled 9 charts
CNS

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡